FA0.F PExA AB (publ)

Healthcare Medical Devices Frankfurt Exchange
0.0218 EUR
Close of Nov 12, 2026
0.0120 0.1000
Market cap
EUR 4.49M
P/E
-
P/B
5.52x
ROE
-52.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is FA0.F undervalued?

Graham number

The Graham number of PExA AB (publ) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PExA AB (publ) fundamental analysis

No fundamental analysis for PExA AB (publ) yet.

PExA AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PExA AB (publ)

PExA AB (publ) develops and commercializes diagnostic products for various respiratory diseases. It offers products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary disease. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrument for the non-invasive collection of particles in exhaled air. The company also pr…

Full company profile